(CYH) Community Health Systems - Overview
Sector: Healthcare | Industry: Medical Care Facilities | Exchange: NYSE (USA) | Market Cap: 395m USD | Total Return: -24% in 12m
Avg Turnover: 3.91M
Qual. Beats: 0
Rev. Trend: 50.7%
Qual. Beats: 1
Warnings
Earnings expected to drop: P/E 0.8 → Forward 17.9
Negative Equity with losses - insolvent profile
Choppy
Tailwinds
No distinct edge detected
Community Health Systems, Inc. (CYH) is a Tennessee-based healthcare provider that owns and operates general acute care hospitals across the United States. The company provides a comprehensive range of medical services, including emergency care, specialty surgery, internal medicine, and rehabilitation. Its business model integrates inpatient facilities with an extensive outpatient network comprising urgent care centers, ambulatory surgery sites, and virtual health platforms.
As a player in the Health Care Facilities sub-industry, CYH operates in a capital-intensive sector where revenue is heavily influenced by government reimbursement rates from Medicare and Medicaid. The industry is currently undergoing a structural shift toward outpatient care models to reduce overhead costs and improve patient accessibility. Examining the companys debt-to-equity ratio on ValueRay can provide further clarity on its financial position. These facilities also serve as critical infrastructure in non-urban markets where competition for acute care services is often limited.
- High debt leverage increases sensitivity to interest rate fluctuations and refinancing costs
- Divestiture of underperforming hospitals impacts total revenue and debt reduction efforts
- Rising labor costs for nursing and medical staff compress operating margins
- Growth in outpatient service volume drives higher margin revenue streams
- Changes in Medicare and Medicaid reimbursement rates affect core hospital profitability
| Net Income: -88.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -2.61 > 1.0 |
| NWC/Revenue: 5.61% < 20% (prev 8.20%; Δ -2.58% < -1%) |
| CFO/TA 0.01 > 3% & CFO 126.0m > Net Income -88.0m |
| Net Debt (10.6b) to EBITDA (4.96b): 2.15 < 3 |
| Current Ratio: 1.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (135.0m) vs 12m ago 1.60% < -2% |
| Gross Margin: 53.66% > 18% (prev 0.42%; Δ 5.32k% > 0.5%) |
| Asset Turnover: 158.7% > 50% (prev 91.10%; Δ 67.63% > 0%) |
| Interest Coverage Ratio: 4.89 > 6 (EBITDA TTM 4.96b / Interest Expense TTM 864.0m) |
| A: 0.09 (Total Current Assets 3.77b - Total Current Liabilities 2.57b) / Total Assets 13.2b |
| B: -0.28 (Retained Earnings -3.63b / Total Assets 13.2b) |
| C: 0.31 (EBIT TTM 4.23b / Avg Total Assets 13.5b) |
| D: -0.26 (Book Value of Equity -3.64b / Total Liabilities 14.1b) |
| Altman-Z'' = 1.53 = BB |
| DSRI: 0.51 (Receivables 2.14b/2.47b, Revenue 21.5b/12.7b) |
| GMI: 0.78 (GM 53.66% / 41.74%) |
| AQI: 0.27 (AQ_t 0.10 / AQ_t-1 0.37) |
| SGI: 1.70 (Revenue 21.5b / 12.7b) |
| TATA: -0.02 (NI -88.0m - CFO 126.0m) / TA 13.2b) |
| Beneish M = -3.58 (Cap -4..+1) = AAA |
As of May 27, 2026, the stock is trading at USD 2.85 with a total of 897,173 shares traded.
Over the past week, the price has changed by +1.79%,
over one month by +1.42%,
over three months by -22.13% and
over the past year by -24.00%.
Community Health Systems has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold CYH.
- StrongBuy: 1
- Buy: 1
- Hold: 5
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 3.3 | 16.1% |
P/E Trailing = 0.814
P/E Forward = 17.8571
P/S = 0.0321
P/B = 0.534
P/EG = 2.3833
Revenue TTM = 21.5b USD
EBIT TTM = 4.23b USD
EBITDA TTM = 4.96b USD
Long Term Debt = 10.1b USD (from longTermDebt, last quarter)
Short Term Debt = 126.0m USD (from shortTermDebt, last quarter)
Debt = 11.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 601.0m
Net Debt = 10.6b USD (calculated: Debt 11.4b - CCE 712.0m)
Enterprise Value = 11.0b USD (394.6m + Debt 11.4b - CCE 712.0m)
Interest Coverage Ratio = 4.89 (Ebit TTM 4.23b / Interest Expense TTM 864.0m)
EV/FCF = -55.20x (Enterprise Value 11.0b / FCF TTM -200.0m)
FCF Yield = -1.81% (FCF TTM -200.0m / Enterprise Value 11.0b)
FCF Margin = -0.93% (FCF TTM -200.0m / Revenue TTM 21.5b)
Net Margin = -0.41% (Net Income TTM -88.0m / Revenue TTM 21.5b)
Gross Margin = 53.66% ((Revenue TTM 21.5b - Cost of Revenue TTM 9.96b) / Revenue TTM)
Gross Margin QoQ = none% (prev -134.6%)
Tobins Q-Ratio = 0.84 (Enterprise Value 11.0b / Total Assets 13.2b)
Interest Expense / Debt = 7.61% (Interest Expense 864.0m / Debt 11.4b)
Taxrate = 6.63% (48.0m / 724.0m)
NOPAT = 3.95b (EBIT 4.23b * (1 - 6.63%))
Current Ratio = 1.47 (Total Current Assets 3.77b / Total Current Liabilities 2.57b)
Debt / Equity = -7.81 (negative equity) (Debt 11.4b / totalStockholderEquity, last quarter -1.45b)
Debt / EBITDA = 2.15 (Net Debt 10.6b / EBITDA 4.96b)
Debt / FCF = -53.23 (negative FCF - burning cash) (Net Debt 10.6b / FCF TTM -200.0m)
Total Stockholder Equity = -1.36b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.65% (Net Income -88.0m / Total Assets 13.2b)
RoE = -3.88% (Net Income TTM -88.0m / Total Stockholder Equity 2.27b)
RoCE = 34.11% (EBIT 4.23b / Capital Employed (Equity 2.27b + L.T.Debt 10.1b))
RoIC = 39.36% (NOPAT 3.95b / Invested Capital 10.0b)
WACC = 7.32% (E(394.6m)/V(11.8b) * Re(13.45%) + D(11.4b)/V(11.8b) * Rd(7.61%) * (1-Tc(0.07)))
Discount Rate = 13.45% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 77.38 | Cagr: 1.00%
[DCF] Fair Price = unknown (Cash Flow -200.0m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.74 | # QB: 0
Revenue Correlation: 50.66 | Revenue CAGR: 9.13% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.11 | Chg30d=+23.38% | Revisions=+33% | Analysts=7
EPS next Quarter (2026-09-30): EPS=-0.03 | Chg30d=+83.55% | Revisions=+33% | Analysts=7
EPS current Year (2026-12-31): EPS=-0.60 | Chg30d=-35.42% | Revisions=-56% | GrowthEPS=-150.7% | GrowthRev=-7.1%
EPS next Year (2027-12-31): EPS=0.11 | Chg30d=N/A | Revisions=-20% | GrowthEPS=+117.7% | GrowthRev=+1.6%
[Analyst] Revisions Ratio: -56%